Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.3300
+0.0050 (1.54%)
Nov 9, 2026, 12:34 PM AEDT
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 97.71 million as of November 6, 2026. It is the 27,720th most valuable company in the world and the 616th biggest in Australia. Its market cap has decreased by 7.53% in one year.
Market Cap
97.71M
Enterprise Value
84.84M
Revenue
282.66K
Global Rank
Country Rank
#616 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 97.71M, an increase of 129.86%. That is a compound annual growth rate of 16.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 97.71M | -15.54% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 157.76M |
| Orthocell | 156.63M |
| Paradigm Biopharmaceuticals | 153.48M |
| Dimerix | 123.08M |
| Nyrada | 122.56M |
| Recce Pharmaceuticals | 100.90M |
| LTR Pharma | 76.56M |
| Prescient Therapeutics | 61.77M |